Skip to Content
Merck
All Photos(2)

Documents

RECYMAG65K27PMX

Millipore

MILLIPLEX® Rat Cytokine/Chemokine Magnetic Bead Panel - Premixed 27 Plex - Immunology Multiplex Assay

Simultaneously analyze multiple cytokine and chemokine biomarkers with Bead-Based Multiplex Assays using the Luminex technology, in rat serum, plasma and cell culture samples.

Synonym(s):

luminex rat cytokine chemokine growth factor multiplex assay, luminex rat pro inflammatory anti inflammatory cytokine panel, millipore rat inflammation multiplex kit, rat interleukin immunoassay panel

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12161503
eCl@ss:
32161000
NACRES:
NA.47

Quality Level

species reactivity

rat

manufacturer/tradename

Milliplex®

assay range

accuracy: 80-131%
standard curve range: 0.2-1,000 pg/mL
(EGF)

standard curve range: 1.2-5,000 pg/mL
(GRO/KC)

standard curve range: 12.2-50,000 pg/mL
(GM-CSF, IL-1α, IL-2, IL-12 (p70), IL-18)

standard curve range: 14.6-60,000 pg/mL
(IFNγ, MIP-1α)

standard curve range: 2.4-10,000 pg/mL
(Fractalkine, IP-10, Leptin, TNFα)

standard curve range: 24.4-100,000 pg/mL
(LIX, MIP-2)

standard curve range: 4.9-20,000 pg/mL
(Eotaxin, C-CSF, IL-4, IL-5, IL-13, RANTES, VEGF)

standard curve range: 7.3-30,000 pg/mL
(IL-10, IL-17A, MCP-1)

standard curve range: 73.2-300,000 pg/mL
(IL-6)

technique(s)

multiplexing: suitable

compatibility

configured for Premixed

detection method

fluorometric (Luminex xMAP)

shipped in

wet ice

General description

The MILLIPLEX® Rat Cytokine/Chemokine Bead Panel (RECYTMAG-65K & RECYMAG65K27PMX) enables you to focus on the therapeutic potential of cytokines, as well as the modulation of cytokine expression.

Panel Type: Cytokines/Chemokines

Specificity

Cross Reactivty
There is no or minimum cross-reactivity between the antibodies and any other analytes in the panel.

Application

  • Analytes: EGF, Eotaxin/CCL11, Fractalkine, G-CSF, GM-CSF, GRO/KC, IFN-γ, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 (p70), IL-13, IL-17A, IL-18, IP-10, Leptin, LIX, MCP-1, MIP-1α, MIP-2, RANTES, TNF-α, VEGF
  • Recommended Sample type: rat serum or plasma
  • Recommended Sample dilution: 1:2
  • Assay Run Time: One day

Other Notes

Sensitivity: Refer to kit protocol for sensitivites for individual cytokines/chemokines

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Signal Word

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

Target Organs

Respiratory Tract

Storage Class Code

10 - Combustible liquids


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Bin Cai et al.
BioMed research international, 2016, 1469590-1469590 (2016-05-20)
Citrulline (Cit) supplementation was proposed to serve as a therapeutic intervention to restore arginine (Arg) concentrations and improve related functions in sepsis. This study explored whether citrulline had positive effects on liver injury and cytokine release in the early stages
Dominic Friston et al.
Disease models & mechanisms, 13(4) (2020-03-05)
Burn injury is a pathology underpinned by progressive and aberrant inflammation. It is a major clinical challenge to survival and quality of life. Although the complex local and disseminating pathological processes of a burn injury ultimately stem from local tissue
Linda W Zhang et al.
Frontiers in neuroscience, 10, 561-561 (2016-12-23)
Magnesium sulfate (MgSO4) is the most widely used therapy in the clinic to prevent the progression of preeclampsia, a hypertensive disorder of pregnancy, to eclampsia. Eclampsia, manifested as unexplained seizures and/or coma during pregnancy or postpartum, accounts for ~13% of
Young Taek Oh et al.
American journal of physiology. Endocrinology and metabolism, 309(2), E154-E160 (2015-05-21)
Inflammation is implicated in metabolic abnormalities in obesity and type 2 diabetes. Because θ-defensins have anti-inflammatory activities, we tested whether RTD-1, a θ-defensin, improves metabolic conditions in diet-induced obesity (DIO). DIO was induced by high-fat feeding in obese-prone CD rats
Jonathan D Finn et al.
Cell reports, 22(9), 2227-2235 (2018-03-01)
The development of clinically viable delivery methods presents one of the greatest challenges in the therapeutic application of CRISPR/Cas9 mediated genome editing. Here, we report the development of a lipid nanoparticle (LNP)-mediated delivery system that, with a single administration, enabled

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service